10 Results for "

PI3K-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "PI3K-IN-2" in MCE Product Catalog:

Cat. No.: HY-101517
CAS No.: 1403458-28-5
Purity:  99.62%
Target:  

PI3K

Research Areas:  

Cancer

PI3K-IN-2 (compound 10) is a potent and orally active PI3Kβ/δ (IC50=7.1/8.6 nM) inhibitor with excellent selectivity versus PI3Kσ and PI3Kγ (IC50=13/190 nM, respectively) .
loading...
    loading...
Cat. No.: HY-146789
CAS No.: 2412195-89-0
Target:  

PI3K

Research Areas:  

Cancer

PI3Kδ/γ-IN-2 is a potent PI3Kδ and PI3Kγ dual inhibitor with IC50s of 1 nM and 4.3 nM, respectively. PI3Kδ/γ-IN-2 has favorable oral bioavailability. PI3Kδ/γ-IN-2 has potential for battling B-cell malignancies .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-156406
CAS No.: 3032439-98-5
Purity:  99.97%
Target:  

PI3K

Research Areas:  

Inflammation/Immunology

PITCOIN4 is a highly selective Class II Alpha PI3K-C2α inhibitor. PITCOIN4 shows nanomolar inhibition of PI3K-C2α and >100-fold selectivity in a general kinase panel .
loading...
    loading...
Cat. No.: HY-101517A
CAS No.: 1403458-27-4
Purity:  99.50%
Target:  

PI3K

Research Areas:  

Cancer

(S)-PI3K-IN-2, an enantiomer of PI3K-IN-2 (HY-101517), is a ΡΙ3Κβ/δ inhibitor, with IC50s of 0.198 and 0.282 μΜ, respectively. (S)-PI3K-IN-2 can inhibit phospho AKT (ser473) in MDA-MB-468 cells (IC50=27 nM) .
loading...
    loading...
Cat. No.: HY-144693
CAS No.: 2281803-33-4
Target:  

MEK PI3K PERK

Research Areas:  

Cancer

MEK/PI3K-IN-2 (compound 6s) is a potent MEK/PI3K inhibitor, with IC50 values of 352 nM (MEK1), 107 nM (PI3Kα), and 137 nM (PI3Kδ), respectively. MEK/PI3K-IN-2 suppresses pAKT and pERK1/2 levels. MEK/PI3K-IN-2 shows anti-proliferative activity against tumor cell lines .
loading...
    loading...
Cat. No.: HY-147912
CAS No.: 2459938-28-2
Target:  

PI3K COX

Research Areas:  

Inflammation/Immunology Cancer

COX-2/PI3K-IN-2 (compound 5f) is a potent PI3K inhibitor with IC50 value of 2.78 nM. COX-2/PI3K-IN-2 is a selective COX-2 inhibitor with Ki value of 3.02 nM. COX-2/PI3K-IN-2 shows anti-inflammatory and anti-cancer properties .
loading...
    loading...
Cat. No.: HY-178485
Research Areas:  

Cancer

SJY26 is a PI3K/HDAC dual-target inhibitor with IC50s of 0.59 nM (PI3Kα and PI3Kδ), 2.02 nM (PI3Kγ), 12.69 nM (PI3Kβ) and 114 nM (HDAC1). SJY26 exhibits potent broad-spectrum anti-proliferative activity, and is particularly sensitive to Jurkat and PC9R cells. SJY26 inhibited the migration of PC9R cells, arrested the cell cycle and induced cell apoptosis. SJY26 reduces AKT phosphorylation, and decreases histone H3 deacetylation (Ac-H3). SJY26 can be used for the studies of non-small cell lung cancer and leukemia .
loading...
    loading...
Cat. No.: HY-151635
CAS No.: 2851067-08-6
Target:  

PI3K VEGFR Apoptosis

Research Areas:  

Cancer

PI3K/VEGFR2-IN-1 is a potent dual PI3K/VEGFR2 inhibitor with IC50 values of 2.21 and 68 μM for PI3K and VEGFR2, respectively. PI3K/VEGFR2-IN-1 induces apoptosis. PI3K/VEGFR2-IN-1 can be used in research of cancer .
loading...
    loading...
Cat. No.: HY-48869
CAS No.: 304645-61-2
PI3K-IN-46 (Intermediate 4) is an intermediate in the synthesis of PI3K inhibitor (2-imino-azolinone-vinyl fused-benzene derivative) that can be used for the research of autoimmune disorders, cardiovascular diseases, and neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-187155
CAS No.: 158778-21-3
Target:  

PI3K

Research Areas:  

Others

Cyclo (Gly-{Tyr (PO3H2)-Val-Pro-Met-Leu) is a binding peptide for the PI3K SH2 domain, as well as an inhibitory peptide for the mitogenic signal transduction-mediating domain. Cyclo (Gly-{Tyr (PO3H2)}-Val-Pro-Met-Leu) binds to the SH2 domain of the phosphorylated PI3K p85 subunit, and the spatial arrangement of its phosphotyrosine residue and methionine residue is associated with this interaction .
loading...
    loading...